Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Theranostics Market, by End User
1.4.2 North America Theranostics Market, by Product
1.4.3 North America Theranostics Market, by Application
1.4.4 North America Theranostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Theranostics Market by End User
4.1 North America Hospitals & Cancer Care Centers Market by Country
4.2 North America Theranostics Centers Market by Country
4.3 North America Research & Academic Centers Market by Country
Chapter 5. North America Theranostics Market by Product
5.1 North America Radiopharmaceuticals Market by Country
5.2 North America Diagnostic Imaging Market by Country
5.3 North America IVD/Biomarker Screening Market by Country
5.4 North America Software & Services Market by Country
Chapter 6. North America Theranostics Market by Application
6.1 North America Prostate Cancer Market by Country
6.2 North America Bone Metastasis Market by Country
6.3 North America Other Cancers Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Theranostics Market by Country
7.1 US Theranostics Market
7.1.1 US Theranostics Market by End User
7.1.2 US Theranostics Market by Product
7.1.3 US Theranostics Market by Application
7.2 Canada Theranostics Market
7.2.1 Canada Theranostics Market by End User
7.2.2 Canada Theranostics Market by Product
7.2.3 Canada Theranostics Market by Application
7.3 Mexico Theranostics Market
7.3.1 Mexico Theranostics Market by End User
7.3.2 Mexico Theranostics Market by Product
7.3.3 Mexico Theranostics Market by Application
7.4 Rest of North America Theranostics Market
7.4.1 Rest of North America Theranostics Market by End User
7.4.2 Rest of North America Theranostics Market by Product
7.4.3 Rest of North America Theranostics Market by Application
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 GE HealthCare Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Siemens Healthineers AG (Siemens AG)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Cardinal Health, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Clarity Pharmaceuticals Ltd
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 SWOT Analysis
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Thermo Fisher Scientific, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Telix Pharmaceuticals Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. ABX advanced biochemical compounds GmbH
8.10.1 Company Overview
8.10.2 SWOT Analysis
Unique Offerings 
